Photoacoustic spectroscopy in the monitoring of breast tumor development: A pre-clinical study

被引:1
作者
Priya, Mallika [1 ]
Rao, Bola Sadashiva Satish [2 ]
Ray, Satadru [3 ]
Mahato, Krishna Kishore [1 ]
机构
[1] Manipal Univ, Sch Life Sci, Biophys Unit, Manipal 576104, Karnataka, India
[2] Manipal Univ, Sch Life Sci, Div Radiobiol & Toxicol, Manipal, India
[3] Manipal Univ, Kasturba Med Collage, Dept Surg Oncol, Manipal 576104, India
来源
PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2014 | 2014年 / 8943卷
关键词
Nude mice; MCF-7; cells; tumor development; Photoacoustic spectroscopy; FFT patterns; MOUSE MODELS; CANCER;
D O I
10.1117/12.2039365
中图分类号
O43 [光学];
学科分类号
070207 ; 0803 ;
摘要
Breast cancer is the most frequently diagnosed cancer type and its detection at an early stage can reduce the mortality rate substantially. With the aim to detect breast cancer early, by studying tumor progression in nude mice, a pulsed laser induced photoacoustic spectroscopy set up has been designed and developed. MCF-7 cells xenografts were developed using six to eight weeks old female nude mice and tumor tissues were extracted on different days (10th, 15th & 20th Day) post injection and the corresponding photoacoustic spectra were recorded at 281nm excitation. A total of 144 time domain spectra were recorded from 36 animals belonging to the three time points (10th, 15th and 20th day post injection) and converted into frequency domains by Fast Fourier Transform (FFT) tools of the MATLAB algorithms and analyzed. The frequency patterns of the tumor masses on 10th, 15th and 20th day of tumor development showed a gradual increase in intensity at certain frequencies, 5.93 x10(3) Hz, 15.9 x10(3) Hz, 29.69 x10(3) Hz and 32.5 x10(3) Hz in the FFT patterns indicating that these frequencies were more sensitive towards tumor development. Further analysis of the data yielded a clear variation in the spectral parameters with progression of the disease suggesting that the technique may be suitable for early detection of the disease. Thus, we expect that the developed setup may be useful in assessing the different phases of tumor development which may have clinical implications.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
    Teran-Navarro, Hector
    Calderon-Gonzalez, Ricardo
    Salcines-Cuevas, David
    Garcia, Isabel
    Marradi, Marco
    Freire, Javier
    Salmon, Erwan
    Portillo-Gonzalez, Mar
    Frande-Cabanes, Elisabet
    Garcia-Castano, Almudena
    Martinez-Callejo, Virginia
    Gomez-Roman, Javier
    Tobes, Raquel
    Rivera, Fernando
    Yanez-Diaz, Sonsoles
    Alvarez-Dominguez, Carmen
    ONCOIMMUNOLOGY, 2019, 8 (02):
  • [42] Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery
    Lundin, Anders
    Porritt, Michelle J.
    Jaiswal, Himjyot
    Seeliger, Frank
    Johansson, Camilla
    Bidar, Abdel Wahad
    Badertscher, Lukas
    Wimberger, Sandra
    Davies, Emma J.
    Hardaker, Elizabeth
    Martins, Carla P.
    James, Emily
    Admyre, Therese
    Taheri-Ghahfarokhi, Amir
    Bradley, Jenna
    Schantz, Anna
    Alaeimahabadi, Babak
    Clausen, Maryam
    Xu, Xiufeng
    Mayr, Lorenz M.
    Nitsch, Roberto
    Bohlooly-Y, Mohammad
    Barry, Simon T.
    Maresca, Marcello
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [43] Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia
    Kane, Alexandra M.
    Liu, Cheng
    Fennell, Lochlan J.
    McKeone, Diane M.
    Bond, Catherine E.
    Pollock, Pamela M.
    Young, Graeme
    Leggett, Barbara A.
    Whitehall, Vicki L. J.
    BRITISH JOURNAL OF CANCER, 2021, 124 (11) : 1820 - 1827
  • [44] Recombinant human DNase I for the treatment of cancer-associated thrombosis: A pre-clinical study
    Varady, Carolina B. S.
    Oliveira, Ana Carolina
    Monteiro, Robson Q.
    Gomes, Taina
    THROMBOSIS RESEARCH, 2021, 203 : 131 - 137
  • [45] Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
    Bownes, Laura, V
    Marayati, Raoud
    Quinn, Colin H.
    Beierle, Andee M.
    Hutchins, Sara C.
    Julson, Janet R.
    Erwin, Michael H.
    Stewart, Jerry E.
    Mroczek-Musulman, Elizabeth
    Ohlmeyer, Michael
    Aye, Jamie M.
    Yoon, Karina J.
    Beierle, Elizabeth A.
    CANCERS, 2022, 14 (08)
  • [46] Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
    Bernhard, Wendy
    Barreto, Kris
    El-Sayed, Ayman
    Gonzalez, Carolina
    Viswas, Raja Solomon
    Toledo, Darien
    Casaco, Angel
    DeCoteau, John
    Fonge, Humphrey
    Geyer, Clarence Ronald
    BMC CANCER, 2021, 21 (01)
  • [47] Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model
    Muqbil, Irfana
    Chaker, Mahmoud
    Aboukameel, Amro
    Mohammad, Ramzi M.
    Azmi, Asfar S.
    Ramchandren, Radhakrishanan
    HELIYON, 2019, 5 (08)
  • [48] Development and Pre-clinical Evaluation of New 68Ga-NOTA-folate Conjugates for PET Imaging of Folate Receptor-positive Tumors
    Aljammaz, Ibrahim
    Al-Otaibi, Basim
    Al-Hokbany, Nourah
    Amer, Suad
    Okarvi, Subhani
    ANTICANCER RESEARCH, 2014, 34 (11) : 6547 - 6556
  • [49] Integrated nomogram to predict HER2 expression in breast tumor: Clinical, Ultrasound, and Photoacoustic imaging approaches
    Chen, Jing
    Yin, Yunqing
    Li, Guoqiu
    Tian, Hongtian
    Ding, Zhimin
    Mo, Sijie
    Xu, Jinfeng
    Huang, Zhibin
    Dong, Fajin
    EUROPEAN JOURNAL OF CANCER, 2024, 209
  • [50] Potentiation of immune checkpoint blockade with a pH-sensitizer as monitored in two pre-clinical tumor models with acidoCEST MRI
    Tran, Renee L.
    Li, Tianzhe
    de la Cerda, Jorge
    Schuler, F. William
    Khaled, Alia S.
    Pudakalakatti, Shivanand
    Bhattacharya, Pratip K.
    Sinharay, Sanhita
    Pagel, Mark D.
    BRITISH JOURNAL OF CANCER, 2025, : 744 - 753